Vesper is one of Lifelines' additional assessments.
This assessment is a collaboration between Lifelines and the Radboudumc centre of expertise on late effects of childhood cancer, with help from the UMCG department of gyneacology.
The goal of the assessment is to quantify male fertility in the general population using a questionnaire, semen analyses, and plasma testosterone measurements.

Vesper started in Q3 of 2019 and will run until 400 male participants have finalized the protocol.
Participants between 18-55 years old are invited:

• to fill in a digital questionnaire about their fertility
• to visit the UMCG department of gyneacology for the donation of a blood sample and
• to produce a fresh semen sample that will be analyzed the same morning.

Inclusion criteria were:

• Male
• 18-55 years old

Exclusion criteria were:

• Being vasectomized
• Working nightshifts
• Survivor of childhood cancer